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Abstract 
Objective: Chronic stress is widespread, and is detrimental to immune functioning and to overall physical and 
emotional health. These effects may be potentiated in patients with chronic illness, as high levels of chronic 
stress are common in this population. Numerous studies support the efficacy of mindfulness-based stress 
reduction (MBSR) in improving psychological functioning. If a strong relationship is found between MBSR and 
immune function, then MBSR may be implemented as a strategy to improve immune functioning and overall 
well-being. Methods: In the present review paper, the relationship between MBSR and immune function is 
evaluated. Empirical studies measuring immune markers as they relate to a standard MBSR intervention were 
reviewed. Relevant articles primarily involved patients with cancer or HIV. Therefore, the associations of 
immune measures with psychological distress are discussed, with an emphasis on patients with these conditions. 
A psychoneuroimmunological (PNI) framework was utilized to propose a mechanism for the relationship 
between MBSR and immune function. Results: Overall, the findings support a positive relationship between 
MBSR intervention and beneficial immunological outcomes. Variability in immune measures assessed across 
studies precludes pooling data to develop more conclusive results. Conclusions: MBSR has been shown to 
consistently improve emotional functioning and quality of life, and these effects appear to facilitate immune 
function.  
Keywords: mindfulness, mindfulness-based stress reduction (MBSR), immune function, natural killer cells, 
mindfulness and cancer, mindfulness and HIV 
1. Introduction 
This literature review presents an investigation of the relationship between MBSR and immune function. This is 
the first literature review devoted to this important relationship. This is a salient area for study as it appears that 
MBSR affects psychosocial variables that correlate with immune functioning, and these relationships may 
represent critical aspects of fighting disease (Shannon, 2005; Sompayrac, 2003). Prior studies have established a 
strong link between psychological distress and reduced immune functioning (Gouin & Kiecolt-Glaser, 2011; 
Kiecolt-Glaser, Dura, Speicher, & Trask, 1991). This is particularly relevant in the case of chronic illness, such 
as HIV and cancer. These conditions are associated with immune supression (Robinson, Mathews, & 
Witek-Janusek, 2003; Sibinga et al., 2008; Witek-Janusek et al., 2008), and this may be compounded by 
emotional distress, which often accompanies these chronic illnesses (Boyer & Paharia, 2008). MBSR has no 
known risks (Praissman, 2008), and it has been shown to improve mood, stress levels, and quality of life 
(Carlson, Speca, Faris, & Patel, 2007; Reibel, Greeson, Brainard, & Rosenzweig, 2001). If evidence further 
supports a strong connection between MBSR and improved immune functioning, this may increase incentives 
for implementing MBSR programs in healthcare settings. The present paper is an evaluation of the existing 
evidence regarding the association between MBSR and immune functioning. Suggestions for future endeavors to 
enhance the evidence-base are provided. 
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2. Background 
2.1 Mindfulness-Based Stress Reduction 
MBSR stems from a structured 8-week program developed by Jon Kabat-Zinn at the University of 
Massachusetts Medical Center in 1979 (Kabat-Zinn, 1990). This program teaches individuals how to cope more 
effectively with stressors and fosters awareness of the present moment. It involves mindful meditation, 
relaxation, and hatha yoga (Kabat-Zinn, 1990; Matousek, Dobkin, & Pruessner, 2010). This program has been 
effective in treating healthy individuals with psychological distress, as well as medical patients with chronic pain, 
cancer, fibromyalgia, rheumatoid arthritis, heart disease, psoriasis, epilepsy, hypertension, and other chronic 
illnesses (Grossman, Nieman, Schmidt, & Walach, 2004; Matchim, & Armer, 2007; Praissman, 2008; Shennan, 
Payne, & Fenlon, 2010 ).   
2.2 Relationship of Chronic Illness and Emotional Stress with Immune Function 
Chronic illness may be emotionally challenging, and research supports the link between chronic psychological 
stress and immune suppression (Cohen, 2005; Glaser et al., 1987; Gouin, & Kiecolt-Glaser, 2011; Kiecolt-Glaser, 
1991; Kiecolt-Glaser et al., 1987; Marucha, Kiecolt-Glaser, & Favagehi, 1998). Approximately 20-25% of 
cancer patients develop depressed mood or anxiety disorders (Antoni, 2003; Armaiz-Pena, Lutgendorf, Cole, & 
Sood, 2009; Colle et al., 2010; Shennan et al., 2010). Although there is no known connection between negative 
affect and cancer development, there is more clear evidence for psychological correlates with cancer progression 
once it has already been diagnosed (Carlson & Speca, 2011; Sephton, Sapolsky, Kraemer, & Spiegel, 2000). For 
instance, social support (Levy, Herberman, Whiteside, & Sanzo, 1990; Maunsell, Brisson, & Deschenes, 1995) 
and a fighting spirit are associated with longer survival rates, while suppression, helplessness, and hopelessness, 
are associated with an unfavorable progression (Carlson & Speca, 2011; Garssen, 2004; Greer, Morris, & 
Pettingale, 1979; Kieviet-Stijnen, Visser, Garssen, & Hudig, 2009; Ledesma & Kumano, 2009). Receiving an 
HIV diagnosis can also be a highly stressful event (Chida & Vedhara, 2009; Jam et al., 2010; Nott, Vedhara, & 
Spickett, 1995), and HIV/AIDS is frequently comorbid with psychiatric disorders. Approximately 22-45% of 
individuals with HIV/AIDS become depressed and 16 to 32% of this population experience anxiety (Boyer & 
Paharia, 2008). Recent literature supports an association between stress and HIV disease progression (Chida & 
Vedhara, 2009; Coates, Stall, Ekstrand, & Solomon, 1989; Irwin, Daniels, Smith, Bloom, & Weiner, 1987; 
Kemeny et al., 1994; Kemeny, Weiner, Duran, & Taylor, 1995). The link between psychological distress, 
immune functioning, and disease progression highlights the need to incorporate psychological interventions into 
treatment for chronic illness.   
3. Review 
3.1 Literature Search Methods 
The present literature review was conducted using the following databases: PsycINFO, Science Direct, Wiley 
Online Library, PubMed, and Medline. Research in this area did not begin to flourish until the early 2000s. 
Therefore, peer-reviewed English language journal articles published between 2000 and 2011 were reviewed. 
Keywords in the search included mindfulness, meditation, MBSR, immune function, immune system, and 
natural killer cells. The following selection criteria were then applied: (a) peer-reviewed empirical study, (b) 
implemented a standard MBSR protocol based on Kabat-Zinn’s (Kabat-Zinn, 1990) program, and (c) gathered 
pre- and post-intervention quantitative measures of immune function. Given these stipulations, the computerized 
database search yielded 8 studies. These articles primarily involved groups of heterogeneous patients, patients 
specifically with cancer or HIV, or healthy participants. Natural killer cell activity was the most commonly 
utilized immune marker, though there was much variation in other immune markers studied, and these selections 
were often based on the physical condition of the participant sample involved. To enhance clarity, the following 
section regarding the relationship between MBSR and immune function is divided into (a) NK cell comparisons 
among all relevant study samples, and (b) all other immune marker comparisons, categorized by health status of 
the sample. 
3.2 MBSR and NK Cell Activity 
Natural killer cells defend against specific intracellular infections, and they can also destroy lymphoid tumor cell 
lines (Buckingham, Gillies, & Cowell, 1997; Shannon, 2005). These cells have been the most frequently 
implemented immune marker for cancer progression because NK cells are cytotoxic to tumor tissue (Spiegel & 
Sephton, 2001) and because reductions in NK activity have been correlated with tumor progression, metastasis, 
and increased tumor burden (Anderson, Kiecolt-Glaser, & Glaser, 1994). Increases in NK cell activity and 
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number, on the other hand, often reflect an improvement in immune functioning (Alter et al., 2011; Fauci, 
Mavilio, & Kottilil, 2005; Robinson et al., 2003).  
In a single-group pre- and post-MBSR intervention design with a heterogeneous patient sample (N = 24), the 
association between emotional status and immune function after completion of an 8-week MBSR program was 
evaluated (Fang et al., 2010). Psychological distress was measured with the Brief Symptom Inventory-18 
(BSI-18; Derogatis, 2001) and quality of life was measured with the Medical Outcomes Survey Short-Form 
(SF-36; Ware & Sherbourne, 1992). Post-intervention results indicated significant reductions in anxiety (t = 3.40, 
p = 0.004) and overall distress, the latter of which was measured by the General Severity Index (t = 2.55, p = 
0.023). There were also improvements in reported quality of life, as indicated by significant changes on the 
physical (t = -2.41, p = 0.029) and mental (t = -2.26, p = 0.039) composite scores. In terms of markers of 
immune function, there were no statistically significant overall changes in NK cells. However, improvements in 
the Mental Component Summary were correlated with significantly increased, and thus improved measures of 
NK cell activity, as measured by LU20 NK and LU20 PBMC (rs = 0.59 and 0.63, respectively, ps < 0.02). 
Improved measures of mental health were also significantly correlated with increases in LU20 NK and LU20 
PBMC (rs = 0.69 and 0.71, respectively, ps < 0.01). This suggests that improvement in psychological well-being, 
upon completion of an MBSR program, was associated with increased and thus improved levels of NK cytolytic 
activity.  
In a non-randomized controlled study evaluating the relationship between MBSR participation and immune 
function, 75 women with early stage breast cancer who had been treated with surgery (but who had not yet 
received chemotherapy), chose to either participate in an MBSR intervention group or in an assessment-only 
control group (Witek-Janusek et al., 2008). Thirty-eight women completed the MBSR intervention and 
associated measures, and 28 control participants completed relevant assessments. Participants also included 30 
age-matched cancer-free individuals to serve as a non-intervention comparison for biological measures. 
Assessments included the Quality of Life Index Cancer Version III (Ferrans, 1990), Jalowiec Coping Scale (JCS; 
Jalowiec, Murphy, & Powers, 1984), and peripheral blood mononuclear NK cell activity (NKCA), and were 
conducted at four time points. MBSR participants reported better quality of life [F = 5.582; df (1, 45); p = 0.023], 
particularly in the psychological-spiritual [F = 12.493; df(1, 44); p = 0.001] and family [F = 4.214; df(1,44); p = 
0.046] domains. There were also significant treatment effects for optimistic [F = 3.504; df(2, 94); p = 0.034] and 
supportive [F = 4.347; df(1, 50); p = 0.04] coping styles. In terms of NKCA measures, there was a significant 
main effect of treatment [F = 7.308; df(1, 47); p = 0.010] and a significant interaction effect between treatment 
and time [F = 3.480; df(3, 141); p = 0.018], indicating that by Time 4, the NKCA of women in the MBSR group 
was greater than that of women in the assessment-only group (p = 0.002). Importantly, at Times 3 and 4, the 
NKCA for the MBSR group, but not the assessment-only group, returned to levels that did not differ (p > 0.05) 
from the cancer-free comparison group.   
Carlson and colleagues (Carlson, Speca, Patel, & Goodey, 2003) conducted a single group pre- and post-MBSR 
intervention design study, in which quality of life, mood, stress, and immune function were assessed in 
individuals with early stage breast (n = 49) and prostate (n = 10) cancer. Six- and 12-month follow-up 
assessments from this study were also reported in a 2007 paper (10). Assessment instruments included the 
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC 
QLQ-C30; Aaronson et al., 1993), the Profile of Mood States (POMS; McNair, Lorr, & Droppelman, 1971), and 
the Symptoms of Stress Inventory (SOSI; Leckie & Thompson, 1979), and NK cell counts were measured. The 
results demonstrated significant post-MBSR improvements in overall global quality of life (t = -2.23, p < 0.05) 
and symptoms of stress (t = 3.23, p < 0.01), though no significant changes were evident in any of the POMS 
scores. The baseline POMS scores were already quite low, and the authors postulated that the lack of change 
may be related to a ceiling effect. In addition, there was no overall change in number of NK cells from pre- to 
post-intervention. The mean of the three post-MBSR quality of life scores were significantly improved, as 
compared to the pre-intervention EORTC score [F(1, 94) = 7.46, p < 0.005]. Significant improvements in overall 
stress also remained at one-year post-MBSR follow-up, and this was seen by the strong effect comparing the 
pre-intervention SOSI score to the average of the post-intervention scores [F(1, 85) = 16.30, p < 0.001). There 
was a significant quadratic effect across the post-intervention, 6-month, and 12-month follow-up periods for the 
NK cell levels, which initially increased and then decreased over time [F(1, 74) = 5.85, p < 0.05].  
Robinson et al. (2003) used a non-randomized design in which patients with HIV selected to participate in either 
an MBSR intervention group (n = 24) or an assessment-only group (n = 10). All participants remained on the 
regular dosage of antiretroviral medication. Data were collected at pre-intervention and post-intervention, or at 
matched times for the assessment-only group, so that within-group and between-group measures could be 
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assessed. Outcome measures included the Perceived Stress Scale (PSS; Cohen & Williamson, 1988), POMS 
(McNair et al., 1971), and the Functional Assessment of HIV Infection (FAHI; Peterman, Cella, Mo, & McCain, 
1997). Immune markers included NK cell activity and number. The immune markers were determined by 
standard chromium release assay and by flow cytometric phenotypic analysis with anti-CD56 and anti-CD16 
antibodies, respectively. No significant within-group changes or between-group differences were found for 
psychological or functional health factors. The authors reported a trend toward an improvement in both POMS 
and FAHI scores, and indicated that the effects on PSS may have been weakened by virtue of termination and 
thus the end of a group support system. Statistical power was insufficient to determine changes in all the 
outcome variables because of the small sample size. However, NK cell activity and number improved both 
within-MBSR group (t = -2.64, p = 0.015 and t = -3.98, p = 0.001, respectively) and between groups (t = 2.05, p 
= 0.049 and t = 3.72, p = 0.001, respectively) when compared to the assessment-only group. In fact, while NK 
cell number and activity increased in the MBSR group, it decreased in the assessment-only comparison group. 
This result suggests that MBSR may be a viable adjunct strategy for improving immune function in individuals 
with HIV.  
3.3 MBSR and Other Markers of Immune Function 
3.3.1 Heterogeneous Patient Population 
In the Fang et al. single-group pre- and post-MBSR intervention study (Fang et al., 2010), levels of C-reactive 
protein (CRP) were also examined in relation to changes in psychological distress and quality of life in a 
heterogeneous patient sample. CRP is the most commonly utilized acute-phase reactant marker of inflammation 
in the body. It mimics the action of antibodies, except it has a wider range of pathogen molecules to which it can 
attach. Increased circulating levels of CRP are indicative of an infection or systemic inflammatory response 
(Hapuarachi, Chalmers, Winefield, & Blake-Mortimer, 2003). This increase has been correlated with recurring 
coronary events post-myocardial infarction (Liuzz, Biasucci, & Gallimore, 1994) and increased risk of diabetes 
(Freeman, Norrie, & Caslake, 2002), but positive outcomes in patients with cancer (Scott et al., 2002). The Fang 
et al. results indicated that, although there was no statistically significant treatment-related change in CRP level 
for the sample as a whole, reductions in CRP correlated with reductions in anxiety and overall distress (rs = 0.64 
and 0.52, respectively; ps < 0.05). Improvement in psychological well-being following an MBSR program was 
therefore associated with improved levels of CRP.  
3.3.2 Cancer Patient Population  
Studies have supported that MBSR has a positive impact in areas such as stress, anxiety, depression, and sleep 
for cancer patients and survivors (e.g., Branstrom, Kvillemo, & Moskowitz, 2010; Shennan et al., 2010). Studies 
have also found promising associations between MBSR and various markers of immune function in this patient 
population.  
In addition to NKCA, Witek-Janusek and colleagues (Witek-Janusek et al., 2008) measured IFN-, IL-4, IL-6, 
and IL-10 immune markers in a non-randomized controlled design study. IFN- is a cytokine important for 
immunity against viral and intracellular bacterial infections, as well as for tumor control. With regard to 
interleukin functions, IL-4 stimulates the proliferation of B-cells and T-cells, as well as the differentiation of 
CD4 cells into Th2 cells, which in turn, produce additional IL-4 cells. IL-6 may act as both a pro-inflammatory 
and anti-inflammatory cytokine (Sompayrac, 2003). Secretion by T cells and macrophages in response to tissue 
damage leads to inflammation. As an anti-inflammatory cytokine, on the other hand, it is mediated through its 
activating effects on IL-1 and IL-10, as well as through its inhibiting effects on TNF- and IL-1 (Shannon, 2005; 
Sompayrac, 2003). This interleukin is involved in diabetes, atherosclerosis, depression, lupus, and rheumatoid 
arthritis, as well as prostate and metastatic cancer (Shannon, 2005). IL-10 is an anti-inflammatory cytokine, 
which has the potential to inhibit pro-inflammatory cytokines, to reduce antigen markers, and to activate T cells, 
mast cells, and B cells (Shannon, 2005; Sompayrac, 2003). Participants included an MBSR early-stage cancer 
patient group (n = 38), an assessment-only early-stage cancer patient group (n = 28), and a cancer-free biological 
measure comparison group (n = 30). Study results showed that there was a significant increase in PBMC 
production of IFN- in the MBSR group, as compared to the assessment-only group, with both a significant main 
effect for treatment [F = 8.193; df(2, 59); p = 0.001], and an interaction effect between treatment and time [F = 
2.981; df(6, 77); p = 0.043]. Furthermore, at the 4-week post-MBSR follow-up, the IFN- levels for the MBSR 
group, but not for the assessment-only group, were comparable to those of the cancer-free comparison group (p > 
0.05). Results also indicated a significantly lower, and thus improved, level of interleukins produced by the 
PBMC cells in the MBSR group, as compared to the assessment-only group. There were main treatment effects 
for IL-4 [F = 12.420; df(1, 33); p = 0.001], IL-6 [F = 5.091; df(1, 33); p = 0.031], and IL-10 [F = 4.822; df(1, 
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33); p = 0.035]. Importantly, at the 4-week post-MBSR follow-up, each of these PBMC interleukin immune 
marker levels in the MBSR group, but not in the assessment-only group, were equivalent to those in the 
cancer-free comparison group (p > 0.05 for IL-4, 6, and 10; Witek-Janusek et al., 2008). 
In the Carlson et al. (2003) single group pre- and post-MBSR intervention design study, measures of immune 
function (aside from NK count) included NKT, B, T total, T helper, and T cytotoxic cell counts, as well as NK 
and T cell production of TNF, IFN-, IL-4, and IL-10. The post-MBSR follow-up results (Carlson et al., 2007) 
revealed no significant change in the overall number of lymphocytes or cell subsets. However, there was a 
significant increase in T cell production of anti-inflammatory IL-4 (t = -3.13, p < 0.01), as well as a significant 
decrease in pro-inflammatory IFN- (t = 2.18, p < 0.05), and NK cell production of IL-10 (t = 2.22, p < 0.05). 
There was also a significant decrease in number of monocytes (t = 2.26, p < 0.05) and an increase in number of 
eosinophils (t = -2.23, p < 0.05), both trends which continued at one-year follow-up [F(1, 79) = 6.74, p < 0.01 
and F(1, 155) = 21.31, p < 0.001, respectively]. These results support a change in cancer-related cytokine 
proliferation following MBSR participation. Unlike more recent studies, there were no significant correlations 
between psychological and immunological change scores at the p < 0.01 level.  
3.3.3 HIV Patient Population  
Several studies have also evaluated the relationship between MBSR and immune function in individuals with 
HIV. In a pilot study conducted in Iran, the CD4 immunological effects of an 8-week MBSR program were 
examined in a single group of patients (n = 6) who tested positive for HIV. Assessment times included pre- and 
post-intervention, as well as 3-, 6-, 9-, and 12-month follow-ups. At each assessment period, the CD4 level 
means were 549.0 (SD = 173.6), 640.2 (SD = 189.4; p = 0.01), 655.3 (SD = 183.4; p =0.001), 638.0 (SD = 167.4; 
p = 0.004), 619.3 (SD = 163.2; p = 0.004), and 595.2 (SD = 165.6; p = 0.04), respectively. No patients received 
antiretroviral therapy, and the researchers inferred that changes in CD4 levels were associated with MBSR 
program participation (Jam et al., 2010).  
These findings are consistent with a recent single-blind randomized control trial design to test the effects of an 
8-week MBSR program (n = 25) compared to a 1-day control stress-reduction education seminar (n = 15) on 
CD4+ T lymphocyte counts in emotionally stressed individuals with HIV (Creswell, Myers, Cole, & Irwin, 
2009). Assessments were conducted at matched time points before and after the MBSR intervention. At baseline, 
both groups endorsed moderate levels of distress (M = 9.8, SD = 3.7), measured with the Patient Health 
Questionnaire-9 (PHQ-9; Spitzer, Williams, Kroenke, & Hornyak, 2000). Results indicated that while CD4+ T 
lymphocytes declined in the control seminar group (ranging from Mpre-seminar = 757, SE = 70 to Mpost-seminar = 572, 
SE = 71), levels remained stable in the MBSR group from pre- to post-intervention (M = 618, SE = 47 to M = 
628, SE = 52 cells/mm3, respectively). This shows a significant time X treatment interaction effect [F(1, 45) = 
5.70, p = 0.02]. In addition, higher rates of attendance among the MBSR group were associated with greater 
CD4+ T lymphocyte levels [t(74) = 2.09, p = 0.04] post-intervention. This suggests that MBSR may be useful as 
an adjunct treatment to attenuate the decline of CD4+T lymphocyte cells in individuals with HIV.  
Robinson et al. (2003) conducted a non-randomized study, in which patients with HIV elected to participate in 
either an MBSR intervention group (n = 24) or an assessment-only group (n = 10).  In addition to NK cell 
number and activity, RANTES (regulated upon activation, normal T-cell expressed and presumably secreted) 
and Stromal-Derived Factor (SDF-1) immune markers were measured. The RANTES represents chemokines that 
compete with HIV for the chemokine receptor type 5 (CCR5) on lymphocytes, while SDF-1 facilitates the spread 
of HIV (Rowland-Jones, Pinheiro, & Kaul, 2001). Therefore, an increase in RANTES and a decrease in SDF-1 
would indicate improved immunity. The results yielded a significant within-group post-MBSR increase in 
RANTES (t = -2.66, p = 0.015), while SDF-1 levels remained stable (t = -0.44, p = 0.666). However, there were 
not within-group changes for the assessment-only comparison group on the measures of RANTES or SDF-1. 
Due to the small sample, there were no significant between-group differences. This study provides limited 
evidence that MBSR may facilitate improvement in immunity among individuals with HIV.  
3.3.4 Healthy Participants  
Davidson et al. (2003) conducted a randomized controlled study examining the effects of an 8-week MBSR 
program (n=25) on immune function, compared with a wait-list control group (n = 16), in healthy employees at a 
biotechnology corporation. At the conclusion of the MBSR program, individuals in both groups were injected 
with the influenza vaccine and antibody titer response levels were obtained 4- and 8-weeks later. The MBSR 
group exhibited a significantly larger increase in antibody titers between weeks 4 and 8 following the 
vaccination, as compared to the controls [t(33) = 2.05, p < 0.05]. These findings support beneficial effects of 
MBSR on immune function.  
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4. Discussion 
There is strong support for improved anxiety, stress, and quality of life following MBSR intervention (e.g., 
Carlson et al., 2003; Fang et al., 2010; Witek-Janusek, 2008). There is mixed support, however, in terms of 
beneficial immune changes post-MBSR intervention, suggesting a small overall effect (Carlson et al., 2003; 
Fang et al., 2010; Robinson et al., 2003; Witek-Janusek et al., 2008). Although each of the 8 studies reviewed 
showed some improvement in immune function, the specific changes were variable. Of the 5 studies that 
included measures of NK cell activity, two demonstrated significant improvement (Robinson et al., 2003; 
Witek-Janusek et al., 2008) and one showed significant improvement only when correlated with beneficial 
emotional changes (Fang et al., 2010). Carlson’s 2003 study did not show significant changes in NK levels at 
post-MBSR intervention, though the 2007 follow-up paper (Carlson et al., 2007) displayed a significant 
quadratic effect. Also unlike the other studies, this one showed no significant correlation between psychological 
and immunological changes. However, in evaluating the current literature base as a whole, there was a trend 
toward favorable immune changes in those individuals who exhibit a greater improvement in psychological 
status. This is indicative of a more moderate effect of MBSR on improved immune function in individuals who 
also gain the most psychological benefit. Natural killer cell activity (Fang et al., 2010; Robinson et al., 2003; 
Witek-Janusek et al., 2008 ), as well as CRP (Fang et al., 2010), interferon (Witek-Janusek et al., 2008), 
interleukin (Witek-Janusek et al., 2008), RANTES (Robinson et al., 2003), and CD4 (Jam et al., 2010, Creswell 
et al., 2009) levels appear moderately correlated with improvements in anxiety and distress following a standard 
MBSR intervention.  
4.1 Proposed Mechanisms  
Stressful stimuli can adversely impact physiological functioning and overall health (Robinson et al., 2003, 
Webber, 2010) through chronic activation of the sympathetic nervous system and hormone-release in the 
hypothalamic-pituitary-adrenal (HPA) axis (Buckingham et al., 1997; Fang et al., 2010), as well as through 
maladaptive coping behaviors (Kendall-Tackett, 2010). On the other hand, these pathways may also account for 
the mechanism by which psychotherapy can positively influence health. Research indicates that MBSR prevents 
negative neuroendocrine-immune and behavioral effects related to chronic stress through relaxation and shifts in 
cognitive, emotional, biological, and behavioral domains (Witek-Janusek et al., 2008).  This has been supported 
by numerous studies demonstrating the psychological benefits associated with MBSR practice. Both healthy and 
chronically ill MBSR participants have experienced significant reductions in stress, anxiety, and depression 
(Carlson et al., 2003; Carlson, Speca, Patel, & Goodey, 2004; Matousek et al., 2010; Speca, Carlson, Goodey, & 
Angen, 2000;, Tacon, Caldera, & Ronaghan, 2004). Practice in MBSR has also been associated with positive 
states of mind (Branstrom et al., 2010; Kieviet-Stijnen et al., 2008), emotional adjustment (Matousek et al., 
2013; Tacon et al., 2004), a fighting spirit (Carlson et al., 2011), an internal locus of control (Carlson et al., 
2004), and a better subjective quality of life (Carlson et al., 2004; Cohen et al., 2005). Such effects are correlated 
with improved psychosocial and health outcomes (Greer et al., 1979).  
Given the well-established association between psychosocial factors and immune function, these beneficial 
psychosocial outcomes may explain the above findings of improved immune functioning in MBSR participants 
(e.g., Fang et al., 2010; Witek-JAnusek et al., 2008). Studies indicate that this process may be mediated by the 
neuroendocrine system, particularly through those components related to the stress response. High levels of 
cortisol, for instance, have been associated with stress, depression, and immune suppression, and such elevations 
have been found in 75% of a sample of metastatic breast and ovarian cancer patients (Touitou, Bogdan, Levi, 
Benavides, & Auzeby, 1996).  
This mechanism is further supported by growing evidence that cortisol levels decrease following participation in 
an MBSR program (Matousek et al., 2010; Robinson et al., 2003). For instance, Carlson et al. (2007) found that 
in a single subject pre- and post-MBSR intervention with 6- and 12-month follow-ups in early stage breast or 
prostate cancer patients (N = 59), cortisol levels decreased consistently. There were significant decreases in 
average cortisol levels from baseline to post-MBSR [F(1, 88) = 19.85, p < 0.001] and at one-year follow-up [F(1, 
28) = 32.50, p < 0.001]. 
4.2 Implications and Future Directions 
Overall, the findings support a relationship between MBSR practice and beneficial immunological outcomes. 
This is important because optimal immune functioning will enhance disease-prevention and the fight against 
existing illness. Such an association is particularly relevant in today’s high stress environment, which is often 
amplified by chronic illness (Boyer & Paharia, 2008). Individuals with chronic illnesses such as cancer or HIV 
may be at a greater risk for a spiral of increasing stress and immune dysregulation (Boyer & Paharia, 2008; 
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Robinson et al., 2003; Shannon et al., 2005). MBSR has no known adverse side-effects (Praissman, 2008), and it 
may therefore serve as an important complementary treatment to break this negative cycle and improve health 
outcomes.  
Several limitations are present within the reviewed research studies, and this often involves the use of study 
designs and measures based on convenience.  Despite the existence of only a limited number of studies in this 
area, there is much variability in the choice of outcome measures, which precludes pooling data to develop more 
conclusive results. This is especially troublesome due to the small sample sizes in the majority of studies, as well 
as much variability in the sample populations and study designs utilized. Some studies implemented single-group 
pre- and post-assessments, while others used an assessment-only control group. A major limitation in not 
including a control group is that it precludes the ability to infer causation related to any changes following 
participation in the MBSR program. In addition, nonspecific factors such as group interaction, expectancy effects, 
and therapeutic alliance, may have beneficial effects and cannot be controlled for in a single group design. 
However, even when a control group was used, the majority of the studies were non-randomized. The frequent 
participant self-selection between MBSR and assessment-only groups may have decreased validity related to 
sampling bias.  
Given the consistent limitations of these studies, the need for statistically rigorous randomized controlled studies 
and larger sample sizes is important in order to more firmly determine the effects of MBSR on immune function. 
It may be helpful to examine the different components of MBSR to determine what the most effective aspects 
are in enhancing both physical and psychological outcomes. This strategy should also be compared to other 
treatment modalities to see whether other techniques might be just as effective. 
Future studies (Table 1) may examine whether mediators, such as change in sleep quality, impact the significant 
correlations between psychological functioning and immune markers. This may lead to more targeted treatment 
interventions.  Importantly, studies that involve longer-term follow-up may help to determine the extent to 
which relevant biological changes impact disease outcomes. It may also be interesting to track whether 
MBSR-related changes in immune markers, such as reduced inflammation, might be directly related to changes 
in specific disease outcomes.  
 
Table 1. Ongoing randomized clinical trials of MBSR and immune function 
Investigator(s) Condition Patients Purpose 
Study 
Completion 
Date 
Fang C67 Cervical Dysplasia 300 
To compare mindfulness-based stress with general health education 
in improving immune response to human papillomavirus in patients 
with cervical dysplasia. 
August 
2012 
Moynihan 
JA68 Psoriasis 200 
To examine and compare the effects of the MBSR program and the 
Living Well (LW) program on adults with psoriasis in terms of how 
these programs may affect their psoriasis, immune function, 
physical and emotional health, and well-being. 
March 2013
Lengacher 
CA69 
Breast 
Cancer 300 
1) To determine the efficacy of the MBSR program in improving 
psychological and physical symptoms, quality of life and measures 
of immune function and a stress hormone (cortisol) 
2) To determine whether positive effects achieved from the MBSR 
program are mediated through changes in mindfulness and fear of 
recurrence of breast cancer. 
3) To determine whether positive effects achieved from the MBSR 
program are modified by specific patient characteristics measured at 
baseline 
December 
2013 
 
Overall, this review indicates a positive relationship between MBSR and immune function (Creswell et al., 2009; 
Davidson et al., 2003; Jam et al., 2010; Robinson et al., 2003; Witek-Janusek, 2008). Though more rigorous 
studies are needed, there is evidence that the mechanisms by which MBSR is effective may include improvement 
in coping skills, mood, and stress levels (Carlson & Speca, 2011). This approach may enhance a patient’s ability 
to take an active role in personal healthcare and maintain quality of life.  
www.ccsenet.org/cco Cancer and Clinical Oncology Vol. 2, No. 1; 2013 
69 
 
References 
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... Haes, J. C. (1993). The 
European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use 
in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76. 
http://dx.doi.org/10.1093/jnci/85.5.365 
Alter, G., Heckerman, D., Schneidewind, A., Fadda, L., Kadie, C. M., Carlson, J. M., ... Altfeld, M. (2011 Aug). 
HIV-1 adaptation to NK-cell-mediated immune pressure. Nature, 476(7358), 96-100. 
http://dx.doi.org/10.1038/nature10237 
Anderson, B. L., Kiecolt-Glaser, J. K., & Glaser, R. (1994). A biobehavioral model of cancer stress and disease 
course. Am Psychol, 49, 389-404. http://dx.doi.org/10.1037/0003-066X.49.5.389 
Antoni, M. H. (2003). Psychoneuroendocrinology and psychoneuroimmunology of cancer: Plausible 
mechanisms worth pursuing? Brain Behav Immun, 17, 84-91. 
http://dx.doi.org/10.1016/S0889-1591(02)00074-0 
Armaiz-Pena, G. N., Lutgendorf, S. K., Cole, S. W., & Sood, A. K. (2009). Neuroendocrine modulation of cancer 
progression. Brain Behav Immun, 23, 10-15. http://dx.doi.org/10.1016/j.bbi.2008.06.007 
Boyer, B. A., & Paharia, M. I. (2008 editors). Comprehensive handbook of clinical health psychology. Hoboken, 
NJ: Wiley. 55-81. 
Branstrom, R., Kvillemo, P., Brandberg, Y., & Moskowitz, J. T. (2010). Self-report mindfulness as a mediator of 
psychological well-being in a stress reduction intervention for cancer patients—A randomized study. Ann 
Behav Med, 39, 151-61. http://dx.doi.org/10.1007/s12160-010-9168-6 
Buckingham, J. C., Gillies, G. E., & Cowell, A-M. (1997 editors). Stress, stress hormones, and the immune 
system. West Sussex, England: Wiley.  
Carlson, L. E., & Speca, M. (2011). Mindfulness-based cancer recovery. Oakland, CA: New Harbinger; 17-31.  
Carlson, L. E., Speca, M., Faris, P., & Patel, K. D. (2007). One year pre-post intervention follow-up of 
psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction in 
breast and prostate cancer outpatients. Brain Behav Immun, 21, 1038-49. 
http://dx.doi.org/10.1016/j.bbi.2007.04.002 
Carlson, L. E., Speca, M., Patel, K. D., & Goodey, E. (2004). Mindfulness-based stress reduction in relation to 
quality of life, mood, symptoms of stress, and levels of cortisol, dehydrepiandrosterone sulfate, and 
melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology, 29, 448-74. 
http://dx.doi.org/10.1016/S0306-4530(03)00054-4 
Carlson, L. E., Speca, M., Patel, K. D., & Goodey, E. (2003). Mindfulness-based stress reduction in relation to 
quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. 
Psychosom Med, 65, 571-81. http://dx.doi.org/10.1097/01.PSY.0000074003.35911.41 
Chida, Y., & Vedhara, K. (2009). Adverse psychosocial factors predict poorer prognosis in HIV disease: A 
meta-analytic review of prospective investigations. Brain Behav Immun, 23, 434-45. 
http://dx.doi.org/10.1016/j.bbi.2009.01.013 
Coates, T. J., Stall, R., Ekstrand, M., & Solomon, G. (1989). Psychological predictors as cofactors for disease 
progression in men infected with HIV: The San Francisco men’s health study. Presented at the V 
International AIDS Conference. Montreal, Canada.  
Cohen, S. (2005). Keynote presentation at the Eighth International Congress of Behavioral Medicine: The 
Pittsburgh common cold studies—Psychosocial predictors of susceptibility to respiratory infectious illness. 
Int J Behav Med, 12, 123-31. http://dx.doi.org/10.1207/s15327558ijbm1203_1 
Cohen, S., & Williamson, A. (1988). Perceived stress in a probability sample of the United States. In: Spacapan 
S, Oskamp S, editors. Social psychology of health. Newbury Park, CA: Sage; p. 31-67. 
Colle, K. F., Vincent, A., Cha, S. S., Loehrer, L. L., Bauer, B. A., Wahner-Roedler, D. L. (2010). Measurement of 
quality of life and participant experience with the mindfulness-based stress reduction program. Complement 
Ther Clin Pract, 16, 36-40. http://dx.doi.org/10.1016/j.ctcp.2009.06.008 
Creswell, J. D., Myers, H. F., Cole, S. W., & Irwin, M. R. (2009). Mindfulness meditation training effects on 
CD4+ T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behav Immun, 23, 
www.ccsenet.org/cco Cancer and Clinical Oncology Vol. 2, No. 1; 2013 
70 
 
184-188. http://dx.doi.org/10.1016/j.bbi.2008.07.004 
Davidson, R. J., Kabat-Zinn, J., Schumacher, J., Rosenkranz, M., Muller, D., Santorelli, S. F., ... Sheridan, J. F. 
(2003). Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med, 65, 
564-70. http://dx.doi.org/10.1097/01.PSY.0000077505.67574.E3 
Derogatis, L. R. (2001). Brief symptom inventory 18: administration, scoring, and procedures manual. 
Minneapolis, MN: Pearson. 
Fang, C. (2012). Mindfulness-Based Stress Reduction or General Health Education improving Immune 
Response to Human Papillomavirus in Patients with Cervical Dysplasia, Fox Chase Cancer Center, PA. , 
www.clinical trials.gov, Identifier: NCT00653146.  
Fang, C. Y., Reibel, D. K., Longacre, M. L., Rosenzweig, S., Campbell, D. E., & Douglas, S. D. (2010). 
Enhanced psychosocial well-being following participation in a mindfulness-based stress reduction program 
is associated with increased natural killer cell activity. J Altern Complement Med, 16, 531-38. 
http://dx.doi.org/10.1089/acm.2009.0018 
Fauci, A. S., Mavilio, D., & Kottilil, S. (2005). NK cells in HIV infection: Paradigm for protection or targets of 
ambush. Nature Reviews Immunology, 5, 835-843. http://dx.doi.org/10.1038/nri1711 
Ferrans, C. E. (1990). Development of a quality of life index for patients with cancer. Oncol Nurse Forum, 17, 
15-19. 
Freeman, D. J., Norrie, J., & Caslake, M. J. (2002). C-reactive protein is an independent predictor of risk for the 
development of diabetes in the west of Scotland coronary prevention study. Diabetes, 51, 1596-1600. 
http://dx.doi.org/10.2337/diabetes.51.5.1596 
Garssen, B. (2004). Psychological factors and cancer development: Evidence after 30 years of research. Clin 
Psychol Rev, 24(3), 315-38. http://dx.doi.org/10.1016/j.cpr.2004.01.002 
Glaser, R., Rice, J., Sheridan, J., Fertel, R., Stout, J., Speicher, C., ... Kiecolt-Glaser, J. (1987). Stress-related 
immune suppression: health implications. Brain Behav Immun, 1, 7-20. 
http://dx.doi.org/10.1016/0889-1591(87)90002-X 
Gouin, J., & Kiecolt-Glaser, J. (2011). The impact of psychological stress on wound healing: methods and 
mechanisms. Immun Allergy Clin North Am, 31, 81-93. http://dx.doi.org/10.1016/j.iac.2010.09.010 
Greer, S., Morris, T., & Pettingale, K. W. (1979). Psychological response to breast cancer: Effect on outcome. 
Lancet, 2(8146), 785-87. http://dx.doi.org/10.1016/S0140-6736(79)92127-5 
Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2004). Mindfulness-based stress reduction and health 
benefits: a meta-analysis. J Psychosom Res, 57, 35-43. http://dx.doi.org/10.1016/S0022-3999(03)00573-7 
Hapuarachchi, J. R., Chalmers, A. H., Winefield, A. H., & Blake-Mortimer, J. S. (2003). Changes in clinically 
relevant metabolites with psychological stress parameters. Behav Med, 29(2), 52-59. 
http://dx.doi.org/10.1080/08964280309596057 
Irwin, M., Daniels, M., Smith, T., Bloom, E., & Weiner, H. (1987). Impaired natural killer cell activity during 
bereavement. Brain Behav Immun, 1, 98-104. http://dx.doi.org/10.1016/0889-1591(87)90011-0 
Jalowiec, A., Murphy, S. P., & Powers, M. J. (1984). Psychometric assessment of the Jalowiec Coping Scale. 
Nurse Res, 33, 157-61. 
Jam, S., Imani, A. H., Foroughi, M., SeyedAlinaghi, S. A., Koochak, H. E., & Mohraz, M. (2010). The effects of 
mindfulness-based stress reduction program in Iranian HIV/AIDS patients: A pilot study. Acta Medica 
Iranica, 48, 101-6. 
Kabat-Zinn, J. (1990). Full catastrophe living. New York: Delta; 1-46.  
Kemeny, M. E., Weiner, H., Duran, R., & Taylor, S. E. (1995). Immune system changes after the death of a 
partner in HIV-positive gay men. Psychosom Med, 57, 547-54. 
Kemeny, M. E., Weiner, H., Taylor, S. E., Schneider, S., Visscher, B., & Fahey, J. L. (1994). Repeated 
bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men. 
Health Psychol, 13, 14-24. http://dx.doi.org/10.1037/0278-6133.13.1.14 
Kendall-Tackett, K. (2010 editor). The psychoneuroimmunology of chronic disease. Washington, DC: American 
Psychological Association. 
www.ccsenet.org/cco Cancer and Clinical Oncology Vol. 2, No. 1; 2013 
71 
 
Kiecolt-Glaser, J. K., Dura, J. R., Speicher, C. E., & Trask, O. J. (1991). Spousal caregivers of dementia victims: 
longitudinal changes in immunity and health. Psychosom Med, 53, 345-62. 
Kiecolt-Glaser, J. K., Fisher, L. D., Ogrocki, P., Stout, J. C., Speicher, C. E., & Glaser, R. (1987). Marital quality, 
marital disruption, and immune function. Psychosom Med, 49, 13-34. 
Kieviet-Stijnen, A., Visser, A., Garssen, B., & Hudig, W. (2008). Mindfulness-based stress reduction training for 
oncology patients: Patient’s appraisal and changes in well-being. Patient Educ Couns, 72, 436-42. 
http://dx.doi.org/10.1016/j.pec.2008.05.015 
Leckie, M. S., & Thompson, E. (1979). Symptoms of stress inventory. Seattle, WA: University of Washington. 
Ledesma, D., & Kumano, H. (2009). Mindfulness-based stress reduction and cancer: A meta analysis. 
Psychooncology, 18, 571-79. http://dx.doi.org/10.1002/pon.1400 
Lengacher, C. A., Johnson-Mallard, V., Post-White, J., Moscoso, M. S., Jacobsen, P. B., Klein, T. W., ... Kip, K. 
E. (2009). Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of 
breast cancer. Psychooncology, 18(12), 1261-72. http://dx.doi.org/10.1002/pon.1529 
Levy, S. M., Herberman, R. B., Whiteside, T., & Sanzo, K. (1990). Perceived social support and tumor 
estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. 
Psychosom Med, 52(1), 73-85. 
Liuzzo, G., Biasucci, L. M., & Gallimore, J. R. (1994). The prognostic value of C-reactive protein and serum 
amyloid A in severe unstable angina. N Engl J Med, 331, 417-24. 
http://dx.doi.org/10.1056/NEJM199408183310701 
Marucha, P. T., Kiecolt-Glaser, J. K., & Favagehi, M. (1998). Mucosal wound healing is impaired by 
examination stress. Psychosom Med, 60, 362-65. http://dx.doi.org/10.1188/07.ONF.1059-1066 
Matchim, Y., & Armer, J. M. (2007). Measuring the psychological impact of mindfulness meditation on health 
among patients with cancer: a literature review. Oncol Nurse, 34, 1059-66. 
Matousek, R. H., Dobkin, P. L., & Pruessner, J. (2010). Cortisol as a marker for improvement in 
mindfulness-based stress reduction. Complement Ther Clin Pract, 16, 13-19. 
http://dx.doi.org/10.1016/j.ctcp.2009.06.004 
Maunsell, E., Brisson, J., & Deschenes, L. (1995). Social support and survival among women with breast cancer. 
Cancer, 76, 631-637. http://dx.doi.org/10.1002/1097-0142(19950815)76:4<631::AID-CNCR2820760414> 
3.0.CO;2-9 
McNair, D. A., Lorr, M., & Droppelman, L. F. (1971). Profile of mood states (POMS). San Diego, CA: 
Educational and Industrial Testing Service. 
Moynihan, J. A. et al. (2011). Improving Psoriasis through Health and Well-Being, University of Rochester, NY. 
Nott, K. H., Vedhara, K., & Spickett, G. P. (1995). Psychology, immunology, and HIV. 
Psychoneuroendocrinology, 20, 451-74. http://dx.doi.org/10.1016/0306-4530(94)00080-T 
Peterman, A. H., Cella, D., Mo, F., & McCain, N. (1997). Psychometric validation of the revised Functional 
Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res, 
6, 572-84. http://dx.doi.org/10.1023/A:1018416317546 
Praissman, S. (2008). Mindfulness-based stress reduction: a literature review and clinician’s guide. J Am Acad 
Nurse Pract, 20, 212-16. http://dx.doi.org/10.1111/j.1745-7599.2008.00306.x 
Reibel, D. K., Greeson, J. M., Brainard, G. C., & Rosenzweig, S. (2001). Mindfulness-based stress reduction and 
health-related quality of life in a heterogeneous patient population. Gen Hosp Psychiatry, 23(4), 183-92. 
http://dx.doi.org/10.1016/S0163-8343(01)00149-9 
Robinson, F. P., Mathews, H. L., & Witek-Janusek, L. (2003). Psycho-endocrine-immune response to 
mindfulness-based stress reduction in individuals infected with the Human Immunodeficiency Virus: a 
quasiexperimental study. J Altern Complement Med, 9, 683-94. 
http://dx.doi.org/10.1089/107555303322524535 
Rowland-Jones, S., Pinheiro, S., & Kaul, R. (2001). New insights into host factors in HIV-1 pathogenesis. Cell, 
104(4), 473-76. http://dx.doi.org/10.1016/S0092-8674(01)00235-5 
Scott, H. R., McMillan, D. C., Forrest, L. M., Brown, D. J., McArdle, C. S., & Milroy, R. (2002). The systemic 
inflammatory response, weight loss, performance status, and survival in patients with inoperable non-small 
www.ccsenet.org/cco Cancer and Clinical Oncology Vol. 2, No. 1; 2013 
72 
 
cell lung cancer. Br J Cancer, 87, 264-67. http://dx.doi.org/10.1038/sj.bjc.6600466 
Sephton, S. E., Sapolsky, R. M., Kraemer, H. C., & Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of 
breast cancer survival. J Natl Cancer Inst, 92(12), 994-1000. http://dx.doi.org/10.1093/jnci/92.12.994 
Shannon, J. B. (2005). Immune system disorders sourcebook. 2nd ed. Detroit. MI: Omnigraphics, 1-671. 
Shennan, C., Payne, S., & Fenlon, D. (2010). What is the evidence for the use of mindfulness-based 
interventions in cancer care? A review. Psychooncology, 20. 
Sibinga, E. M., Stewart, M., Magyari, T., Welsh, C. K., Hutton, N., & Ellen, J. M. (2008). Mindfulness-based 
stress reduction for HIV-infected youth: a pilot study. Explore, 4, 36-7. 
http://dx.doi.org/10.1016/j.explore.2007.10.002 
Sompayrac, L. (2003). How the immune system works. 2nd ed. Malden, MA: Blackwell; 1-130 
Speca, M., Carlson, L. E., Goodey, E., & Angen, M. (2000). A randomized wait-list controlled clinical trial: The 
effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in 
cancer outpatients. Psychosom Med, 62, 613-22. 
Spiegel, D., & Sephton, S. E. (2001). Psychoneuroimmune and endocrine pathways in cancer: effects of stress 
and support. Sem Clin Neuropsych, 6, 252-65. http://dx.doi.org/10.1053/scnp.2001.26995 
Spitzer, R. L., Williams, J. B., Kroenke, K., Hornyak, R., & McMurray, J. (2000). Validity and utility of the 
PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the 
PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol, 183, 
759-769. http://dx.doi.org/10.1067/mob.2000.106580 
Tacon, A. M., Caldera, Y. M., & Ronaghan, C. (2004). Mindfulness-based stress reduction in women with breast 
cancer. Fam Syst Health, 22, 193-203. http://dx.doi.org/10.1037/1091-7527.22.2.193 
Touitou, Y., Bogdan, A., Levi, F., Benavides, M., & Auzeby, A. (1996). Disruption of the circadian patterns of 
serum cortisol in breast and ovarian cancer patients: relationships with tumor marker antigens. Br J Cancer, 
74, 1248-52. http://dx.doi.org/10.1038/bjc.1996.524 
Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): conceptual 
framework and item selection. Medical Care, 30, 473-83. 
http://dx.doi.org/10.1097/00005650-199206000-00002 
Webber, M. A. (2010). Psychoneuroimmunological outcomes and quality of life. Transfus Apher Sci, 42, 157-61. 
http://dx.doi.org/10.1016/j.transci.2010.01.014 
Witek-Janusek, L., Albuquerque, K., Chroniak, K. R., Chroniak, C., Durazo-Arvizu, R., & Mathews, H. L. 
(2008). Effect of mindfulness based stress reduction on immune function, quality of life and coping in 
women newly diagnosed with early stage breast cancer. Brain Behav Immun, 22, 969-81. 
http://dx.doi.org/10.1016/j.bbi.2008.01.012 
 
